Important publication from collaborating Chicago centers with @jaltmanmd from @LurieCancer showing that structural racism accounts for survival disparities in AML more than molecular features/treatment.
Structural racism is terrible & should end.
pubmed.ncbi.nlm.nih.gov/3506…
Congrats to Dr. Ishan Roy for being named as a collaborator of a new $150,000 award from the @The_HFoundation to @LurieCancer. This pilot could improve the standard of care for patients with glioblastoma. Dr. Roy’s research will focus on rehabilitation & cancer survivorship.
Cachexia is a muscle wasting syndrome that many cancer patients experience. Ishan Roy, MD, PhD, is beginning research to help early identification of patients who may develop it. This can lead to earlier treatment, resulting in better patient outcomes. bit.ly/3FgfyaY
Unique work from Ishan Roy @AbilityLab based on in-patient rehabilitation for patients with cancer shows limits of grip strength as a readout for mobility #cancercachexia2021 and highlights need for payer reimbursement of rehabilitation for patients with #cancercachexia#cachexia